Table 4 FSFI scores in 50 women affected by idiopathic OAB symptoms and sexual dysfunction, before and 12 weeks after treatment with oral Mirabegron, 50 mg/day
From: The impact of Mirabegron on sexual function in women with idiopathic overactive bladder
Patients (No.) | FSFI Total Score baseline (mean ± SD) | FSFI Total Score 12-weeks f-up (mean ± SD) |
|---|---|---|
Continent (28) | 22 ± 3.7 | 27.5 ± 3.5 |
Incontinent (22) | 14.1 ± 3.1 | 21 ± 3.2 |